TPOXX
NDC 50072-200, tecovirimat monohydrate, capsule, from SIGA Technologies, Inc..
- Product NDC
- 50072-200
- Status
- Listed
- Labeler
- SIGA Technologies, Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA208627
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50072-200 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TECOVIRIMAT MONOHYDRATE200 mg/1
Pharmacologic classes
Breast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 3A Inducers [MoA]; Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50072-200-42 | 50072020042 | 42 CAPSULE in 1 BOTTLE (50072-200-42) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/fce826ab-4d6a-4139-a2ee-a304a913a253
Use it
Look up 50072-200 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50072-200 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50072-200. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.